A 13-step synthesis of (+)-cyanthiwigin-AC (2) from (+)-Hajos-Parrish ketone derivative 8b and dimesylate 9c employing deconjugative spirobisalkylation strategy is described.
[EN] CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS [FR] INHIBITEURS DE CDK ET LEUR UTILISATION EN TANT QUE PRODUITS PHARMACEUTIQUES
摘要:
The disclosure is directed to compounds of Formula (I), pharmaceutical compositions comprising compounds of Formula (I), as well as methods of their use and preparation, are also described.
[EN] CYCLOHEXYL SULPHONE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS<br/>[FR] UTILISATION DE DERIVES DE CYCLOHEXYLE SULFONE COMME INHIBITEURS DE LA GAMMA-SECRETASE
申请人:MERCK SHARP & DOHME
公开号:WO2004031137A1
公开(公告)日:2004-04-15
Compounds of formula (I) inhibit the processing of APP by gamma-secretase, and hence are useful in treatment of Alzheimer's disease.
式(I)的化合物抑制γ-分泌酶对APP的加工,因此在治疗阿尔茨海默病方面是有用的。
Sulphonamido-Substituted Cyclohexyl Sulphones for Treatment of Cancer
申请人:Lewis Huw David
公开号:US20090215775A1
公开(公告)日:2009-08-27
Compounds of formula (I) are disclosed for treatment of cancer.
公式(I)的化合物已被披露用于治疗癌症。
[EN] CYCLOHEXYL SULPHONES AS GAMMA-SECRETASE INHIBITORS<br/>[FR] SULFONES CYCLOHEXYLIQUES TELS QUE DES INHIBITEURS DE GAMMA-SECRETASE
申请人:MERCK SHARP & DOHME
公开号:WO2004031139A1
公开(公告)日:2004-04-15
Compounds of formula (I) inhibit the processing of APP by gamma-secretase, and hence are useful in treating or preventing Alzheimer's disease.
式(I)的化合物抑制γ-分泌酶对APP的加工,因此对治疗或预防阿尔茨海默病有用。
Gamma-secretase inhibitors
申请人:Nadin John Alan
公开号:US20050075320A1
公开(公告)日:2005-04-07
Compounds of formula I:
inhibit the processing of APP by gamma-secretase and hence find use in treatment of Alzheimer's disease.
公式I的化合物:抑制γ-分泌酶对APP的处理,因此可用于治疗阿尔茨海默病。
Synthesis of 6,5-fused bicyclic lactams as potential dipeptide β-turn mimetics
作者:Rudolf Mueller、Laszlo Revesz
DOI:10.1016/s0040-4039(00)73120-0
日期:1994.6
The first short synthesis of the dipeptide mimetic (3S, 6S, 9S)-6-amino-5-oxoindolizidine-3-carboxylic acid 1 and its Z-protected derivative 9 is described, employing the Schoellkopf bislactim-ether methodology, followed by a highly specific intramolecular reductive amination and spontaneous lactamization. These 6,5-fusedbicycliclactams may be viewed as conformationally restricted alanyl-proline